Literature DB >> 3582485

Plasma protein binding of furosemide in the elderly.

G M Pacifici, A Viani, H U Schulz, H J Frercks.   

Abstract

The protein binding of furosemide was investigated in plasma from 22 old and 11 young subjects by equilibrium dialysis. The unbound fraction of furosemide was 3.16% in plasma from the elderly and 1.7% in plasma from the young. A significant correlation was found between the unbound fraction of furosemide and the plasma concentration of albumin. The average number of binding sites was 3.8 (elderly) and 2.7 (young) 10(-6) mol/g albumin. The average association constant (K) was 4.3 (elderly) and 4.2 (young) 10(5) M-1. By increasing the concentration of furosemide up to 200 micrograms/ml buffer the unbound fraction of the drug rose to 5.2% (elderly) and 3.5% (young).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582485     DOI: 10.1007/bf00542196

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

Review 1.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

2.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

3.  Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.

Authors:  D Rudman; T J Bixler; A E Del Rio
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

4.  Functional defects in the aging kidney.

Authors:  S A Friedman; A E Raizner; H Rosen; N A Solomon; W Sy
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.

Authors:  S Hall; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

7.  Effect of plasma protein binding on renal clearance of drugs.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

8.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

9.  Furosemide kinetics and dynamics in aged patients.

Authors:  A L Kerremans; Y Tan; H van Baars; C A van Ginneken; F W Gribnau
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

10.  Role of binding in distribution of furosemide: where is nonrenal clearance?

Authors:  R A Branch
Journal:  Fed Proc       Date:  1983-04
View more
  4 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Acute Renal Failure of Nosocomial Origin.

Authors:  Mark Dominik Alscher; Christiane Erley; Martin K Kuhlmann
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

Review 3.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 4.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.